Substance

ID:349370

Names and Identifiers
IUPAC Traditional name
atovaquone
IUPAC name
2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydronaphthalene-1,4-dione
Synonyms
Meprontrans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedioneAtovaquone
Registration numbers
CAS Number
Properties
Safety Information
European Hazard Symbols
Nature polluting Nature polluting (N)
Risk Statements
50/53
MSDS Link
Safety Statements
60-61
RTECS
QJ5616500
German water hazard class
3
Storage Temperature
-20°C
Physical Property
Apperance
yellow powder
Solubility
DMSO: >10 mg/mL
Product Information
Purity
≥98% (HPLC)
Empirical Formula (Hill Notation)
C22H19ClO3
Molecule Details
Application
Atovaquone inhibits the cytochrome bc(1) complex via interactions with the Rieske iron-sulfur protein and cytochrome b in the ubiquinol oxidation pocket. In addition to its use as a treatment for toxoplasmosis, atovaquone has antimalarial properties and prevents pneumocystis pneumonia post-renal transplant.
Biochem/physiol Actions
Atovaquone is an anti-protozoal mitochondrial electron transport inhibitor; Antimalarial; Antipneumocystic, and has also been used to treat toxoplasmosis. It is an analog of protozoan mitochondrial protein ubiquinone, and acts by inhibiting the cytochrome bc(1) complex via interactions with the Rieske iron-sulfur protein and cytochrome b in the ubiquinol oxidation pocket.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data